BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 18083760)

  • 41. SNEV(Prp19/PSO4) deficiency increases PUVA-induced senescence in mouse skin.
    Monteforte R; Beilhack GF; Grausenburger R; Mayerhofer B; Bittner R; Grillari-Voglauer R; Sibilia M; Dellago H; Tschachler E; Gruber F; Grillari J
    Exp Dermatol; 2016 Mar; 25(3):212-7. PubMed ID: 26663487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of homologous recombination in DNA interstrand crosslink repair.
    Hinz JM
    Environ Mol Mutagen; 2010 Jul; 51(6):582-603. PubMed ID: 20658649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA interstrand cross-link repair: understanding role of Fanconi anemia pathway and therapeutic implications.
    Shukla P; Solanki A; Ghosh K; Vundinti BR
    Eur J Haematol; 2013 Nov; 91(5):381-93. PubMed ID: 23859405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Further characterization of the role of Pso2 in the repair of DNA interstrand cross-link-associated double-strand breaks in Saccharomyces cerevisiae.
    Dudás A; Vlasáková D; Dudásová Z; Gabcová D; Brozmanová J; Chovanec M
    Neoplasma; 2007; 54(3):189-94. PubMed ID: 17447848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advances in understanding the complex mechanisms of DNA interstrand cross-link repair.
    Clauson C; Schärer OD; Niedernhofer L
    Cold Spring Harb Perspect Biol; 2013 Oct; 5(10):a012732. PubMed ID: 24086043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin.
    De Silva IU; McHugh PJ; Clingen PH; Hartley JA
    Nucleic Acids Res; 2002 Sep; 30(17):3848-56. PubMed ID: 12202770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of the Nedd8 system sensitizes cells to DNA interstrand cross-linking agents.
    Kee Y; Huang M; Chang S; Moreau LA; Park E; Smith PG; D'Andrea AD
    Mol Cancer Res; 2012 Mar; 10(3):369-77. PubMed ID: 22219386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting and processing of site-specific DNA interstrand crosslinks.
    Vasquez KM
    Environ Mol Mutagen; 2010 Jul; 51(6):527-39. PubMed ID: 20196133
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation.
    Stecklein SR; Kumaraswamy E; Behbod F; Wang W; Chaguturu V; Harlan-Williams LM; Jensen RA
    Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13650-5. PubMed ID: 22869732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The differences between ICL repair during and outside of S phase.
    Williams HL; Gottesman ME; Gautier J
    Trends Biochem Sci; 2013 Aug; 38(8):386-93. PubMed ID: 23830640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Damage-dependent regulation of MUS81-EME1 by Fanconi anemia complementation group A protein.
    Benitez A; Yuan F; Nakajima S; Wei L; Qian L; Myers R; Hu JJ; Lan L; Zhang Y
    Nucleic Acids Res; 2014 Feb; 42(3):1671-83. PubMed ID: 24170812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Replication-Independent ICL Repair: From Chemotherapy to Cell Homeostasis.
    Ahmed A; Kato N; Gautier J
    J Mol Biol; 2024 Jul; 436(13):168618. PubMed ID: 38763228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repair of DNA interstrand cross-links: interactions between homology-dependent and homology-independent pathways.
    Zheng H; Wang X; Legerski RJ; Glazer PM; Li L
    DNA Repair (Amst); 2006 May; 5(5):566-74. PubMed ID: 16569514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA repair defects channel interstrand DNA cross-links into alternate recombinational and error-prone repair pathways.
    Saffran WA; Ahmed S; Bellevue S; Pereira G; Patrick T; Sanchez W; Thomas S; Alberti M; Hearst JE
    J Biol Chem; 2004 Aug; 279(35):36462-9. PubMed ID: 15213235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human SNM1B is required for normal cellular response to both DNA interstrand crosslink-inducing agents and ionizing radiation.
    Demuth I; Digweed M; Concannon P
    Oncogene; 2004 Nov; 23(53):8611-8. PubMed ID: 15467758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NEIL3-mediated proteasomal degradation facilitates the repair of cisplatin-induced DNA damage in human cells.
    Aliyaskarova U; Baiken Y; Renaud F; Couve S; Kisselev AF; Saparbaev M; Groisman R
    Sci Rep; 2023 Mar; 13(1):5174. PubMed ID: 36997601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Ercc
    Wong A; Kieu T; Robbins PD
    Aging (Albany NY); 2020 Dec; 12(24):24481-24483. PubMed ID: 33353886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks.
    Mukherjee A; Vasquez KM
    J Vis Exp; 2016 Nov; (117):. PubMed ID: 27911399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imaging the cellular response to an antigen tagged interstrand crosslinking agent.
    Bellani MA; Huang J; Zhang J; Gali H; Thazhathveetil AK; Pokharel D; Majumdar I; Shaik A; Seidman MM
    DNA Repair (Amst); 2023 Aug; 128():103525. PubMed ID: 37320956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Orchestrating the nucleases involved in DNA interstrand cross-link (ICL) repair.
    Sengerová B; Wang AT; McHugh PJ
    Cell Cycle; 2011 Dec; 10(23):3999-4008. PubMed ID: 22101340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.